Catalyst Wire Dossier Catalyst Wire Dossier

ICATIBANT

icatibant · Alembic Pharmaceuticals Limited
Drug timelines are a Plus or Pro feature.

28 regulatory and trial events tracked for ICATIBANT, covering 2012-02-17 to 2026-01-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study Observing US Patients With HAE Type I or II Who Take Icatibant to Treat HAE Attacks

See pricing